Stay updated on Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Sign up to get notified when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.

Latest updates to the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA minor version update from v3.4.1 to v3.4.2 was applied to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page; no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Results Submitted and Locations sections to the study page, including state-level site listings (Arizona, California, Florida, Michigan, Missouri, Ohio). Updated to Revision: v3.3.3.SummaryDifference0.6%

- Check93 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page deleted a government-funding notice about potential delays and operating status, which is a site-wide notice rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Efgartigimod SC in Bullous Pemphigoid: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efgartigimod SC in Bullous Pemphigoid: Clinical Trial page.